123 related articles for article (PubMed ID: 17287465)
1. Characterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong islet allograft survival.
Fiorina P; Jurewicz M; Tanaka K; Behazin N; Augello A; Vergani A; von Andrian UH; Smith NR; Sayegh MH; Abdi R
Diabetes; 2007 Apr; 56(4):912-20. PubMed ID: 17287465
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of CC chemokine-induced migration of murine CD8alpha+ and CD8alpha- dendritic cells and their in vivo trafficking.
Colvin BL; Morelli AE; Logar AJ; Lau AH; Thomson AW
J Leukoc Biol; 2004 Feb; 75(2):275-85. PubMed ID: 14597730
[TBL] [Abstract][Full Text] [Related]
4. Distinctive role of donor strain immature dendritic cells in the creation of allograft tolerance.
Kim YS; Yang SH; Kang HG; Seong EY; Lee SH; Gao W; Kenny J; Zheng XX; Strom TB
Int Immunol; 2006 Dec; 18(12):1771-7. PubMed ID: 17068105
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and functional differences between wild-type and CCR2-/- dendritic cells: implications for islet transplantation.
Fiorina P; Jurewicz M; Vergani A; Augello A; Paez J; Ricchiuti V; Tchipachvili V; Sayegh MH; Abdi R
Transplantation; 2008 Apr; 85(7):1030-8. PubMed ID: 18408585
[TBL] [Abstract][Full Text] [Related]
6. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy.
Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW
Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395
[TBL] [Abstract][Full Text] [Related]
7. Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway.
Wang L; Han R; Lee I; Hancock AS; Xiong G; Gunn MD; Hancock WW
J Immunol; 2005 Nov; 175(10):6311-8. PubMed ID: 16272282
[TBL] [Abstract][Full Text] [Related]
8. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking.
Ziegler E; Gueler F; Rong S; Mengel M; Witzke O; Kribben A; Haller H; Kunzendorf U; Krautwald S
J Am Soc Nephrol; 2006 Sep; 17(9):2521-32. PubMed ID: 16899521
[TBL] [Abstract][Full Text] [Related]
9. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival].
Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868
[TBL] [Abstract][Full Text] [Related]
10. Prolonged islet allograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes.
Rossi L; Migliavacca B; Pierigé F; Serafini S; Sanvito F; Olivieri S; Nano R; Antonioli B; Magnani M; Bertuzzi F
Transplantation; 2008 Feb; 85(4):648-50. PubMed ID: 18347547
[TBL] [Abstract][Full Text] [Related]
11. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice.
Dufour JM; Lord SJ; Kin T; Rayat GR; Dixon DE; Bleackley RC; Korbutt GS; Rajotte RV
Cell Transplant; 2008; 16(10):1029-38. PubMed ID: 18351019
[TBL] [Abstract][Full Text] [Related]
12. Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice.
Bouma G; Coppens JM; Mourits S; Nikolic T; Sozzani S; Drexhage HA; Versnel MA
Eur J Immunol; 2005 Aug; 35(8):2386-96. PubMed ID: 16047341
[TBL] [Abstract][Full Text] [Related]
13. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
[TBL] [Abstract][Full Text] [Related]
14. Role of intra-islet endothelial cells in islet allo-immunity.
Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
[TBL] [Abstract][Full Text] [Related]
15. The role of macrophage migration inhibitory factor in mouse islet transplantation.
Toso C; Serre-Beinier V; Emamaullee J; Merani S; Armanet M; Wojtusciszyn A; Bosco D; Calandra T; Roger T; Morel P; Shapiro AM; Berney T
Transplantation; 2008 Nov; 86(10):1361-9. PubMed ID: 19034004
[TBL] [Abstract][Full Text] [Related]
16. Selective depletion of cross-presenting dendritic cells enhances islet allograft survival.
Sutherland RM; Zhan Y; Carrington EM; Londrigan SL; Lew AM
Cell Transplant; 2011; 20(3):467-74. PubMed ID: 20887666
[TBL] [Abstract][Full Text] [Related]
17. Accelerated antibody-mediated graft loss of rodent pancreatic islets after pretreatment with dexamethasone-treated immature donor dendritic cells.
de Kort H; Crul C; van der Wal AM; Schlagwein N; Stax AM; Bruijn JA; van Kooten C; de Heer E
Transplantation; 2012 Nov; 94(9):903-10. PubMed ID: 23047455
[TBL] [Abstract][Full Text] [Related]
18. IL-12p40 is not required for islet allograft rejection.
Bi EG; Shi W; Zou J; Hao ZH; Li ZH; Cai D; Zhang HQ; Sun B
Acta Pharmacol Sin; 2006 Aug; 27(8):1065-70. PubMed ID: 16867260
[TBL] [Abstract][Full Text] [Related]
19. CCL21-induced immune cell infiltration.
Ashour AE; Turnquist HR; Singh RK; Talmadge JE; Solheim JC
Int Immunopharmacol; 2007 Feb; 7(2):272-6. PubMed ID: 17178395
[TBL] [Abstract][Full Text] [Related]
20. [Rapamycin combined with donor bone marrow-derived immature dendritic cells induces mouse skin allograft tolerance].
Yu S; He X; Hu A; Fu BM; Ma Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):399-402. PubMed ID: 18359700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
